#diabetes

#diabetes

Sugary drinks contribute to gut microbiome changes and increased diabetes risk in Hispanic or Latino populations.

Sugary drinks contribute to over 2 million diabetes cases and 1 million heart disease cases globally each year, with significant impact in low-income regions.

CDC reports diabetes deaths in the U.S. have significantly decreased after an increase during the COVID-19 pandemic.

A new oral drug, orforglipron, offers a promising alternative to GLP-1 injections for diabetes and weight loss.

Tirzepatide has shown potential in significantly reducing the risk of diabetes in people with prediabetes, highlighting its role in early intervention.

New oral weight loss medications could significantly improve obesity and diabetes management in low- and middle-income countries.

Drugs originally developed for diabetes show potential for weight loss and health benefits for chronic diseases related to aging.

Norma Lyons transformed her health and lifestyle within 90 days to reverse prediabetes without medication.

GLP-1 medications like Mounjaro show promising long-term weight loss potential, with participants losing significant weight over a period of 22 months.

Regular physical activity significantly reduces the risk of type 2 diabetes, with just 150 minutes a week being effective.

Ozempic weight-loss drugs may increase the risk of arthritis and pancreatitis despite their benefits in lowering other health risks.

Over one-third of U.S. adults have prediabetes, highlighting the need for proactive health management.

Lifestyle interventions and metformin can significantly reduce diabetes risk in prediabetic individuals.

The commitment of clinical trial staff can profoundly influence participants' health behaviors.

Eli Lilly's orforglipron offers a stab-free treatment for diabetes and obesity, with potential FDA approval enhancing its market presence.

Eli Lilly's new obesity and diabetes drug 'orforglipron' faces challenges due to its complicated name.

Maternal diabetes during pregnancy significantly increases the risk of neurodevelopmental disorders in children.

Maternal diabetes is linked to a higher risk of neurodevelopmental issues in children, emphasizing the importance of screening and treatment.

Gila monster venom aids in developing diabetes and obesity treatments.

Exendin-4 from Gila monster venom serves as a long-lasting GLP-1 analogue.

Lotte Bjerre Knudsen's research was pivotal in transforming short-acting GLP-1 hormones into successful long-acting diabetes treatments like Ozempic.

Michelle Trachtenberg died of diabetes complications at 39; her death initially listed as undetermined was confirmed after lab review.

Michelle Trachtenberg died from complications of diabetes at age 39, with no autopsy performed due to family religious objections.

Michelle Trachtenberg died from complications of diabetes at age 39.

Michelle Trachtenberg died of natural causes due to complications from diabetes.

Smart insulin can regulate itself based on blood glucose levels, preventing hypoglycemia.

Research indicates COVID-19 vaccines may lack long-lived plasma cells, limiting long-term immunity.

The quest for glucose-responsive insulin seeks to prevent hypoglycaemia while maintaining optimal glucose control.

Engineering glucose-responsive properties in insulin itself offers a promising alternative to existing methods for diabetes management.

A Christian sect in Australia was convicted for the manslaughter of an 8-year-old girl due to the denial of life-saving insulin.

The case emphasizes the tensions between religious beliefs and medical necessity.

Parents and members of their sect were found guilty of manslaughter for withholding insulin from a diabetic girl who died.

Ozempic has been approved to reduce complications for patients with type 2 diabetes and chronic kidney disease.

Ozempic is increasingly recognized for its wider therapeutic potential beyond type 2 diabetes and obesity.

AI is influencing medical research, especially in diabetic eye care.

Regular screenings for diabetic retinopathy can prevent vision loss.

Patient support is essential for managing the emotional impact of diabetes.